| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 211,235 | 209,372 | 193,674 | 202,491 | | Cost of Revenue | 22,624 | (48,724) | 91,649 | (207,923) | | | Gross Profit | 188,611 | 258,096 | 102,025 | 410,414 | | | Operating Expenses | | Research Development | 52,660 | 63,601 | 60,019 | 67,022 | | Selling General and Administrative | 158,353 | 241,268 | 87,556 | 388,705 | | Non Recurring | 1,377 | 11,376 |
-
| 54,926 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (22,402) | (58,149) | (45,550) | (100,239) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,790 | 700 | 3,023 | 5,250 | | Earnings Before Interest And Taxes | (19,612) | (57,449) | (42,527) | (94,989) | | Interest Expense | 5,670 | 4,923 | 4,427 | 9,082 | | Income Before Tax | (25,282) | (62,372) | (46,954) | (104,071) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (25,282) | (62,372) | (46,954) | (104,071) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (26,659) | (62,372) | (46,954) | (104,071) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($26,659) | ($62,372) | ($46,954) | ($104,071) |
|
0.05% Nasdaq 
Income Statement
